Sermorelin & GHRP-6 & GHRP-2 Blend (9mg)
$88.00
Sermorelin & GHRP-6 & GHRP-2 Blend (9mg) is offered by Biotech Peptides for laboratory and analytical research. This blend combines a growth hormone-releasing hormone analogue with two growth hormone secretagogue receptor agonists for studies of receptor signaling and neuroendocrine pathways.pubchem.ncbi.nlm.nih
-
Product: Sermorelin & GHRP-6 & GHRP-2 Blend
-
Listed quantity: 9 mg
-
Components: Sermorelin, GHRP-6, and GHRP-2
-
Intended use: Laboratory and analytical research only
Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.
For research use only. Not for human consumption.
Sermorelin & GHRP-6 & GHRP-2 Blend (9mg) for Laboratory Research
Sermorelin & GHRP-6 & GHRP-2 Blend (9mg) is offered by Biotech Peptides for laboratories investigating growth hormone regulatory signaling, receptor convergence, and neuroendocrine feedback pathways. The blend combines Sermorelin, a GHRH analogue, with GHRP-6 and GHRP-2, two synthetic growth hormone secretagogues.
For laboratories looking to buy Sermorelin & GHRP-6 & GHRP-2 Blend, this listing identifies a 9 mg quantity. Confirm the supplied material’s component ratio, salt state, and analytical characteristics against the requirements of the intended work.
Explore our research peptides for sale to review other laboratory-use listings.
Blend Product Information
| Property | Listing information |
|---|---|
| Product name | Sermorelin & GHRP-6 & GHRP-2 Blend |
| Listed quantity | 9 mg |
| Components | Sermorelin, GHRP-6, and GHRP-2 |
| Intended application | Laboratory and analytical research |
| Documentation inquiries | Include the product name and batch or lot number, where available |
The 9 mg designation describes the total quantity stated for this listing. It does not independently establish the amount of each component, net peptide content, or confirm that a particular quantity-assay method has been performed.
Reference Molecular Characteristics
The following characteristics describe the reference structures of the three components. They are not analytical confirmation of an individual commercial blend batch.
| Component | Reference molecular formula | Approximate molecular weight | PubChem identifier |
|---|---|---|---|
| Sermorelin | C₁₄₉H₂₄₆N₄₄O₄₂S | 3357.9 g/mol | 16132413 |
| GHRP-6 | C₄₆H₅₆N₁₂O₆ | 873.0 g/mol | 4345065 |
| GHRP-2 | C₄₅H₅₅N₉O₆ | 818.0 g/mol | 6918245 |
The molecular formulas and molecular weights are documented in the PubChem Sermorelin reference record, the PubChem GHRP-6 reference record, and the PubChem Pralmorelin reference record. Confirm the supplied salt state and any counterions against manufacturer specifications before using reference values in analytical calculations.
Sermorelin Receptor Research
Sermorelin is a synthetic 29-amino-acid peptide corresponding to the amino-terminal segment of endogenous human growth hormone-releasing hormone. It is also called GHRH(1-29)-NH2 or GRF(1-29) amide.pubchem.ncbi.nlm.nih+1
Sermorelin engages the growth hormone-releasing hormone receptor, a class B G protein-coupled receptor. Receptor engagement is associated in research systems with adenylate cyclase activation, increased intracellular cyclic AMP, and downstream protein kinase A signaling.pubchem.ncbi.nlm.nih+1
GHRP-6 and GHRP-2 Receptor Research
GHRP-6 and GHRP-2 are synthetic hexapeptides that act as agonists at the growth hormone secretagogue receptor subtype GHS-R1a. Activation of this receptor has been associated in research models with Gq/G11-mediated phospholipase C signaling, inositol trisphosphate production, and intracellular calcium mobilization.
GHRP-2 is also known as Pralmorelin and KP-102. GHRP-6 is also known as growth hormone-releasing hexapeptide and Hexapeptide-2.Comparative Signaling Research
In vitro studies of isolated ovine and rat pituitary somatotroph cultures examined differential intracellular signaling triggered by GHRP-2 and GHRP-6. The investigators reported that GHRP-2 increased intracellular cyclic AMP in a manner comparable to growth hormone-releasing factor, while GHRP-6 did not produce measurable cyclic AMP increases despite stimulating growth hormone release.
When administered together at maximal concentrations, GHRP-2 and GHRP-6 exhibited additive effects on growth hormone secretion. The investigators interpreted this as evidence of non-redundant receptor engagement and signaling outputs within the same cellular system.
Combined-Exposure Research
In vitro research using ovine somatotroph cell cultures evaluated combined exposure to growth hormone-releasing hormone and GHRP-2. The investigators reported time-dependent increases in messenger RNA encoding growth hormone, pituitary transcription factor-1, the GHRH receptor, and the growth hormone secretagogue receptor.
These findings apply to a specific cell-based exposure protocol. They do not establish that a commercial blend reproduces the same gene-expression changes, receptor signaling, or biological outcomes in humans.
Research Limitations
Published Sermorelin, GHRP-6, and GHRP-2 research examines receptor signaling, cell-based assays, and animal models. It does not establish that a commercial blend increases growth hormone, improves body composition, supports recovery, enhances sleep, or treats any condition.
Published research also does not verify the identity, purity, component ratio, quantity, or biological activity of the commercial blend supplied with this listing.
Documentation and Batch Verification
Before selecting Sermorelin & GHRP-6 & GHRP-2 Blend (9mg), review the information associated with the exact material being supplied. Depending on your protocol, relevant documentation may include:
-
Product name and batch or lot identifier.
-
Manufacturer specifications and chemical form.
-
Component ratio and total blend quantity.
-
Salt state and counterion information, where applicable.
-
Identity-testing methods and reported results.
-
Purity-testing methods and supporting analytical data.
-
Quantity or peptide-content measurements, where required.
-
Product-specific storage and handling instructions.
Match identifiers across the label, specifications, and analytical reports. Obtain clarification if the documentation uses inconsistent component ratios, sequences, or molecular values.
For inquiries, provide “Sermorelin & GHRP-6 & GHRP-2 Blend (9mg),” the batch number where available, and the specific information your laboratory requires.
Storage and Handling
Follow the product-specific instructions supplied with the material and your laboratory’s applicable procedures.
Do not transfer storage temperatures, shelf-life claims, or preparation instructions from another supplier’s formulation or a differently modified peptide. Obtain clarification if documented instructions are unavailable or unclear.
Frequently Asked Questions About Sermorelin & GHRP-6 & GHRP-2 Blend (9mg)
What is Sermorelin & GHRP-6 & GHRP-2 Blend?
It is a research blend combining Sermorelin, a GHRH analogue, with GHRP-6 and GHRP-2, two synthetic growth hormone secretagogues.
What does the 9mg designation mean?
It is the total quantity stated for this listing. It does not describe the amount of each component, a concentration, or independently establish net peptide content.
Does this blend increase growth hormone?
Published research examines receptor signaling and growth hormone secretion in specific cell-based and animal models. It does not establish that a commercial blend increases growth hormone in humans.
Does published research verify this product?
No. Publications describe the materials and conditions used by the investigators. Assess a commercial blend using relevant manufacturer specifications and analytical evidence.
Where can I find delivery information?
Review our shipping information for current order-processing and delivery terms.
Research Use Only
Sermorelin & GHRP-6 & GHRP-2 Blend (9mg) is sold for laboratory and analytical research only. Not for human or animal consumption, personal administration, medical treatment, diagnosis, or veterinary application.
Review our Research-Use-Only Policy before ordering.
| Brand | Biotech Peptides |
|---|
Related products
CJC-1295 (Mod GRF 1-29) & Ipamorelin & GHRP-2 Blend (9mg)
CJC-1295 (Mod GRF 1-29) & Ipamorelin & GHRP-2 Blend (9mg) is offered by Biotech Peptides for laboratory and analytical research. This blend combines a 29-residue GHRH analogue, a 5-residue ghrelin mimetic, and a 6-residue ghrelin mimetic for studies of receptor signaling and neuroendocrine pathways. 1096
-
Product: CJC-1295 (Mod GRF 1-29) & Ipamorelin & GHRP-2 Blend
-
Listed quantity: 9 mg
-
Components: CJC-1295, Ipamorelin, and GHRP-2
-
Intended use: Laboratory and analytical research only
Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.
For research use only. Not for human consumption.
CJC-1295 & GHRP-2 Blend (10mg)
CJC-1295 & GHRP-2 Blend (10mg) is offered by Biotech Peptides for laboratory and analytical research. This reference blend combines CJC-1295 without DAC, a modified GHRH(1-29) analogue, with GHRP-2, a synthetic ghrelin-receptor agonist.
-
Product: CJC-1295 & GHRP-2 Blend
-
Components: CJC-1295 without DAC and GHRP-2
-
Listed quantity: 10 mg
-
Intended use: Laboratory and analytical research only
Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.
For research use only. Not for human consumption.
CJC-1295 & GHRP-6 Blend (10mg)
CJC-1295 & GHRP-6 Blend (10mg) is offered by Biotech Peptides for laboratory and analytical research. This blend combines CJC-1295, a 29-residue GHRH analogue, with GHRP-6, a 6-residue ghrelin mimetic, for studies of receptor signaling and neuroendocrine pathways. 1101
-
Product: CJC-1295 & GHRP-6 Blend
-
Listed quantity: 10 mg
-
Components: CJC-1295 and GHRP-6
-
Intended use: Laboratory and analytical research only
Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.
For research use only. Not for human consumption.
CJC-1295 & Ipamorelin Blend (10mg)
CJC-1295 & Ipamorelin Blend (10mg) is offered by Biotech Peptides for laboratory and analytical research. This blend combines CJC-1295, a 29-residue GHRH analogue, with Ipamorelin, a 5-residue ghrelin mimetic, for studies of receptor signaling and neuroendocrine pathways. 1099
-
Product: CJC-1295 & Ipamorelin Blend
-
Listed quantity: 10 mg
-
Components: CJC-1295 and Ipamorelin
-
Intended use: Laboratory and analytical research only
Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.
For research use only. Not for human consumption.
Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg)
Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg) is offered by Biotech Peptides for laboratory and analytical research. This blend combines a 16-residue growth hormone fragment, a 29-residue GHRH analogue, and a 5-residue ghrelin mimetic for studies of receptor signaling and neuroendocrine pathways. 1096
-
Product: Fragment 176-191 & CJC-1295 & Ipamorelin Blend
-
Listed quantity: 12 mg
-
Components: Fragment 176-191, CJC-1295, and Ipamorelin
-
Intended use: Laboratory and analytical research only
Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.
For research use only. Not for human consumption.
Mod GRF 1-29 & GHRP-2 Blend (10mg)
Mod GRF 1-29 & GHRP-2 Blend (10mg) is offered by Biotech Peptides for laboratory and analytical research. This blend combines Mod GRF 1-29, a 29-residue GHRH analogue, with GHRP-2, a 6-residue ghrelin mimetic, for studies of receptor signaling and neuroendocrine pathways. 1092
-
Product: Mod GRF 1-29 & GHRP-2 Blend
-
Listed quantity: 10 mg
-
Components: Mod GRF 1-29 and GHRP-2
-
Intended use: Laboratory and analytical research only
Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.
For research use only. Not for human consumption.
Mod GRF 1-29 & Ipamorelin Blend (10mg)
Mod GRF 1-29 & Ipamorelin Blend (10mg) is offered by Biotech Peptides for laboratory and analytical research. This blend combines Mod GRF 1-29, a 29-residue GHRH analogue, with Ipamorelin, a 5-residue ghrelin mimetic, for studies of receptor signaling and neuroendocrine pathways. 1086
-
Product: Mod GRF 1-29 & Ipamorelin Blend
-
Listed quantity: 10 mg
-
Components: Mod GRF 1-29 and Ipamorelin
-
Intended use: Laboratory and analytical research only
Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.
For research use only. Not for human consumption.
Sermorelin & Ipamorelin Blend (10mg)
-
Product: Sermorelin & Ipamorelin Blend
-
Listed quantity: 10 mg
-
Components: Sermorelin and Ipamorelin
-
Intended use: Laboratory and analytical research only
Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.
For research use only. Not for human consumption.
